Ophthalmology in Monterey, CA
11 verified ophthalmology doctors in Monterey.
Ophthalmologists are physicians who provide complete eye care, including surgery for eye disease.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Charles Whisler, MD
Ophthalmology
CMS Open Payments· $120.62 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$120.62
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Charles Whisler do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Gustavo Gonzalez, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ronald Friedman, MD
Ophthalmology
CMS Open Payments· $50.27 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$50.27
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Ronald Friedman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Leland Rosenblum, MD
Ophthalmology
CMS Open Payments· $1,287 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,287
Total received
34
Transactions
13
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Leland Rosenblum do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Philip Penrose, MD
Ophthalmology
CMS Open Payments· $784.00 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$784.00
Total received
38
Transactions
8
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Philip Penrose do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Eric Del Piero, MD
Ophthalmology
CMS Open Payments· $242.63 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$242.63
Total received
4
Transactions
2
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 64th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Eric Del Piero do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Geoffrey White, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Anna Shi, MD
Ophthalmology
CMS Open Payments· $1,406 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,406
Total received
32
Transactions
12
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Anna Shi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Braden Burckhard, MD
Ophthalmology
CMS Open Payments· $46.79 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$46.79
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Braden Burckhard do not imply any wrongdoing. Many are meals, education, or research support.
Dr. James Halpern, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Juliet Del Piero, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.